(Q33853089)

29 July 2017

1 reference

title

Management of cancer treatment-related diarrhea. Issues and therapeutic strategies (English)

1 reference

29 July 2017

0 references

12

Vokes E

1 reference

29 July 2017

4

Champlin RE

1 reference

29 July 2017

Kornblau S

1

1 reference

29 July 2017

Benson AB

2

1 reference

29 July 2017

Catalano R

3

1 reference

29 July 2017

Engelking C

5

1 reference

29 July 2017

Field M

6

1 reference

29 July 2017

Ippoliti C

7

1 reference

29 July 2017

Lazarus HM

8

1 reference

29 July 2017

Mitchell E

9

1 reference

29 July 2017

Rubin J

10

1 reference

29 July 2017

Stiff PJ

11

1 reference

29 July 2017

Wadler S

13

1 reference

29 July 2017

publication date

1 February 2000

1 reference

Journal of Pain and Symptom Management

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

118-129

1 reference

Severe life-threatening toxicities observed in study using leucovorin with 5-fluorouracil

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Necrotizing colitis in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Morphometric analysis of the effects of antineoplastic drugs on mucosa of normal ileum and ileal anastomoses in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Diarrhea in terminally ill patients: Pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

The fate of parental strain small lymphocytes in F1 hybrid rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Bone marrow origin of immunologically competent lymphocytes in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Denuded bowel after recovery from graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Control of chemotherapy-induced diarrhea with octreotide. A randomized trial with placebo in patients receiving cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Phase I trial of the somatostatin analog octreotide acetate in the treatment of fluoropyrimidine-induced diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Octreotide acetate in refractory bone marrow transplant-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2899%2900149-9

7 January 2021

10.1016/S0885-3924(99)00149-9

Identifiers

DOI

1 reference

29 July 2017

1 reference